[ORGANIZATION]
CRIS Contra el Cáncer
Featured in 3 tracked stories · first seen
Also covered in
-
Ponatinib trial shows 68% treatment‑free remission in CML
[HEALTH] · 2 sources ·
[ORGANIZATION]
Featured in 3 tracked stories · first seen
[HEALTH] · 2 sources ·